Washington Trust Bank’s Genomic Health, Inc. GHDX Stock Holding History

Washington Trust Bank’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-100	Closed	-$2K	–	810
2015 Q3	$2K	Hold	100	–	–	﹤0.01%	743
2015 Q2	$3K	Hold	100	–	–	﹤0.01%	750
2015 Q1	$3K	Hold	100	–	–	﹤0.01%	762
2014 Q4	$3K	Hold	100	–	–	﹤0.01%	815
2014 Q3	$3K	Hold	100	–	–	﹤0.01%	769
2014 Q2	$3K	Hold	100	–	–	﹤0.01%	822
2014 Q1	$3K	Buy	+100	New	+$2.87K	﹤0.01%	781

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Washington Trust Bank's GHDX Position: Q4 2015 in Review

Washington Trust Bank sold out of Genomic Health, Inc. (GHDX) in Q4 2015, closing a stake of 100 shares — an estimated $2K sold.

Washington Trust Bank first reported a position in GHDX in Q1 2014 and held it in 7 quarters. The position peaked at $3K in Q2 2015. 132 funds tracked by Wall St. Rank hold GHDX as of Q4 2015.

Washington Trust Bank reported no remaining Genomic Health, Inc. position as of Q4 2015 after selling out during the quarter.
Washington Trust Bank sold 100 Genomic Health, Inc. shares in Q4 2015, an estimated $2K.
Washington Trust Bank first reported a position in Genomic Health, Inc. in Q1 2014 and held it in 7 quarters.
Washington Trust Bank's Genomic Health, Inc. position peaked at $3K in Q2 2015.
132 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2015.

Based on Washington Trust Bank's 13F filing for Q4 2015, filed 21 Jan 2016.